Showing results (121-130 of 126) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Science Translational Medicine|July 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapyYi Sun, Wei Chen, Robert J Torphy, et al.The Journal of Experimental Medicine|February 9, 2024
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.Nature Communications|December 4, 2015
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotypeShunlei Duan, Guohong Yuan, Xiaomeng Liu, et al.Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.Science Immunology|April 28, 2023
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8<sup>+</sup> T cellsEric Y Helm, Tomas Zelenka, Valeriu B Cismasiu, et al.Nature Communications|October 2, 2021
CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cellsMyung-Chul Kim, Nicholas Borcherding, Kawther K Ahmed, et al.Pageof 13